Cargando…

Adoptive T Cell Therapy Targeting CD1 and MR1

Adoptive T cell immunotherapy has demonstrated clinically relevant efficacy in treating malignant and infectious diseases. However, much of these therapies have been focused on enhancing, or generating de novo, effector functions of conventional T cells recognizing HLA molecules. Given the heterogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Tingxi, Chamoto, Kenji, Hirano, Naoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440381/ https://www.ncbi.nlm.nih.gov/pubmed/26052329 http://dx.doi.org/10.3389/fimmu.2015.00247

Ejemplares similares

Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors
por: Guo, Tingxi, et al.
Publicado: (2016)

CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells
por: Nakatsugawa, Munehide, et al.
Publicado: (2016)

Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
por: Kumar, Alok, et al.
Publicado: (2020)

CD1d- and MR1-Restricted T Cells in Sepsis
por: Szabo, Peter A., et al.
Publicado: (2015)

Editorial: CD1- and MR1-Restricted T Cells in Antimicrobial Immunity
por: Haeryfar, S.M. Mansour, et al.
Publicado: (2015)

Role of CD1d- and MR1-Restricted T Cells in Asthma
por: Iwamura, Chiaki, et al.
Publicado: (2018)

The Role of CD1d and MR1 Restricted T Cells in the Liver
por: Huang, Wenyong, et al.
Publicado: (2018)

DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
por: Kagoya, Yuki, et al.
Publicado: (2018)

Editorial: Role of CD1- and MR1-Restricted T Cells in Immunity and Disease
por: Iwabuchi, Kazuya, et al.
Publicado: (2019)

CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies
por: Smith, Corinne J., et al.
Publicado: (2016)

PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
por: Rataj, Felicitas, et al.
Publicado: (2018)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017)

Genetic Modification of CD8(+) T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies
por: Lozano, Teresa, et al.
Publicado: (2019)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
por: Wang, Zhidong, et al.
Publicado: (2020)

Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
por: Olguín-Contreras, Luis Felipe, et al.
Publicado: (2021)

Cancer immunotherapies targeting the PD-1 signaling pathway
por: Iwai, Yoshiko, et al.
Publicado: (2017)

Human CD4(+)CD25(+)CD226(-) Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4(+)CD25(+)CD127(lo/-) Tregs for Adoptive Cell Therapy
por: Brown, Matthew E., et al.
Publicado: (2022)

HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway
por: Yamashita, Yuki, et al.
Publicado: (2017)

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer
por: Bazargan, Sarah, et al.
Publicado: (2023)

Editorial: Implementing Logic Gates in Adoptive Cell Therapy
por: Gross, Gideon, et al.
Publicado: (2022)

Adoptive B cell therapy for chronic viral infection
por: Chung, Young Rock, et al.
Publicado: (2022)

MR1-Restricted T Cells Are Unprecedented Cancer Fighters
por: Vacchini, Alessandro, et al.
Publicado: (2020)

Local Irradiation Sensitized Tumors to Adoptive T Cell Therapy via Enhancing the Cross-Priming, Homing, and Cytotoxicity of Antigen-Specific CD8 T Cells
por: Lai, Jin-Zhi, et al.
Publicado: (2019)

Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies
por: Stone, Jennifer D., et al.
Publicado: (2013)

Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation
por: Zhang, Ping, et al.
Publicado: (2019)

Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans
por: Swarbrick, Gwendolyn M., et al.
Publicado: (2020)

Immune metabolism in PD-1 blockade-based cancer immunotherapy
por: Kumar, Alok, et al.
Publicado: (2020)

Nanoparticles for Enhanced Adoptive T Cell Therapies and Future Perspectives for CNS Tumors
por: Balakrishnan, Preethi Bala, et al.
Publicado: (2021)

Editorial: Expert opinions and perspectives in adoptive cell therapy for cancer: 2022
por: Martín-Antonio, Beatriz
Publicado: (2023)

PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8(+) T Cells
por: Bowers, Jacob S., et al.
Publicado: (2017)

Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2021)

Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation
por: Ashley, Caroline L., et al.
Publicado: (2023)

Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions
por: Sanz-Ortega, Laura, et al.
Publicado: (2019)

Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens
por: Zhao, Yuan, et al.
Publicado: (2012)

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
por: Bianchi, Valentina, et al.
Publicado: (2020)

Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
por: Lloyd, Angharad, et al.
Publicado: (2013)

To Remember or to Forget: The Role of Good and Bad Memories in Adoptive T Cell Therapy for Tumors
por: Mondino, Anna, et al.
Publicado: (2020)

Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy
por: Ge, Wu, et al.
Publicado: (2022)

Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma
por: Liang, Linjun, et al.
Publicado: (2023)

In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy
por: Giehl, Esther, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0ca52ho4qq4ig47ts1c0k079ip